These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31911650)

  • 1. Urinary NT-proBNP as a potential noninvasive biomarker for screening of pulmonary hypertension in preterm infants: a pilot study.
    Naeem B; Ayub A; Aly AM; Malloy MH; Okorodudu AO; Jain SK
    J Perinatol; 2020 Apr; 40(4):628-632. PubMed ID: 31911650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
    Montgomery AM; Bazzy-Asaad A; Asnes JD; Bizzarro MJ; Ehrenkranz RA; Weismann CG
    Neonatology; 2016; 109(3):190-4. PubMed ID: 26780635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M
    J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary NT-proBNP and ductal closure in preterm infants.
    Czernik C; Metze B; Müller C; Bührer C
    J Perinatol; 2013 Mar; 33(3):212-7. PubMed ID: 22743407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    Dasgupta S; Aly AM; Malloy MH; Okorodudu AO; Jain SK
    J Perinatol; 2018 Sep; 38(9):1252-1257. PubMed ID: 29977013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.
    Khan SS; Sithisarn T; Bada HS; Vranicar M; Westgate PM; Hanna M
    J Perinatol; 2017 Dec; 37(12):1319-1324. PubMed ID: 28906496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
    Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants.
    Tosse V; Pillekamp F; Verde P; Hadzik B; Sabir H; Mayatepek E; Hoehn T
    Neonatology; 2012; 101(4):260-6. PubMed ID: 22222353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
    Rodriguez-Blanco S; Oulego-Erroz I; Gautreaux-Minaya S; Perez-Muñuzuri A; Couce-Pico ML
    J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP as an Early Marker of Diastolic Ventricular Dysfunction in Very-Low-Birth-Weight Infants.
    Zafra-Rodríguez P; Méndez-Abad P; Lubián-López SP; Benavente-Fernández I
    Pediatr Cardiol; 2019 Aug; 40(6):1165-1170. PubMed ID: 31175403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.
    Celik IH; Erdeve O; Demırel G; Canpolat FE; Dilmen U
    Early Hum Dev; 2013 Mar; 89(3):187-9. PubMed ID: 23084575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
    Khan S; Concina VA; Schneider D; Westgate P; Arriagada S; Bada H
    Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2021 Apr; 180(4):1193-1201. PubMed ID: 33141298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Trend of Urinary N Terminal Probrain Natriuretic Peptide in Extremely Low Birth Weight Infants during the Neonatal Period.
    Khan SS; Bada HS; Torres M; Almodovar M; Hanna M
    Am J Perinatol; 2022 Jul; 39(10):1027-1032. PubMed ID: 34753181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of NT-proBNP in ventilator weaning for preterm infants with RDS.
    Zhang Q; Shi ZY; Luo CH; Wang L; Zhang SS; Cheng XR; Zhang Q; Xu QY; Guo HX; Cheng XY; Sheng GY
    Pediatr Pulmonol; 2014 Aug; 49(8):757-63. PubMed ID: 24019216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
    Letshwiti JB; Sirc J; O'Kelly R; Miletin J
    Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.